# FDA recall D-0660-2021

> **CIPLA** · Class II · drug recall initiated 2021-06-10.

## Product

Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, Goa, India Manufactured for Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL, 33323, NDC 69097-261-02.

## Reason for recall

CGMP Deviations

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0660-2021
- **Recalling firm:** CIPLA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-06-10
- **Report date:** 2021-07-21
- **Termination date:** 2024-01-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Warren, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0660-2021

## Citation

> AI Analytics. FDA recall D-0660-2021. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-0660-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*